Navigation Links
China Shenghuo Announces Additional Roll-Out of '12 Ways' Cosmetics Products to Watsons Stores
Date:12/9/2008

KUNMING, China, Dec. 9 /PRNewswire-Asia-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Alternext US: KUN) ("China Shenghuo" or the "Company"), today announced that the Company is expanding its herbal-based "12 Ways" cosmetics products into additional Watsons Personal Stores in strategic markets in Mainland China.

The Company has already launched its "12 Ways" brand of cosmetics products to eleven stores of the Watsons Your Personal Store ("Watsons Stores") in seven cities in China. Watsons Stores is the largest health and beauty retailer in China and Asia. By the end of December, the Company expects to enter an additional eleven Watsons stores in eight different cities including Shenzhen and Guangzhou. Furthermore, the Company is planning to add an additional eleven stores by early 2009 to include cities such as Shanghai and Kunming.

"Watsons Stores is an excellent entry point for China Shenghuo to introduce our high-end '12 Ways' cosmetics products," Mr. Gui Hua Lan, Chief Executive Officer of China Shenghuo, said. "We believe our partnership with Watsons and our anticipated success will give us a greater marketing platform to continue our expansion into other markets."

"12 Ways" cosmetics contain natural ingredients including herbal anti- irritants and anti-oxidants as well as Sanchi, which is the key ingredient for the Company's pharmaceutical products. Introduced in September of 2007, "12 Ways" is the Company's Sanchi-based cosmetics product lines that feature products varying from eye, face and skin creams to shampoos. The Company has already launched a total of 37 different cosmetics products for sale. The "12 Ways" products that are being rolled out to Watsons include Panax Notoginseng Moisture Series, Danshen Spots Fade Series, Yunnan Bamboo Anti-Acne Series, Snow Poria Whitening Series, Sunscreen Series and Eye Care Series.

About Watsons Your Personal Store

Watsons Your Personal Store ("Watsons Stores") is one of the largest health and beauty retail chains in Asia. Currently, Watsons Stores operates in thirteen different markets include Hong Kong, Mainland China, Taiwan, Singapore, Malaysia, Thailand, Indonesia, Macau, Korea, the Philippines, Turkey, Estonia and Slovenia and offers more than 25,000 products in over 1,600 outlets. For additional detail regarding Watsons and its corporate parent A.S. Watson Group, please see http://www.aswatson.com .

About China Shenghuo

Founded in 1995, China Shenghuo is a specialty pharmaceutical company that focuses on the research, development, manufacture and marketing of Sanchi- based medicinal and pharmaceutical, nutritional supplement and cosmetic products. Through its subsidiary, Kunming Shenghuo Pharmaceutical (Group) Co., Ltd., it owns thirty SFDA (State Food and Drug Administration) approved medicines, including the flagship product Xuesaitong Soft Capsules, which has already been listed in the Insurance Catalogue. At present, China Shenghuo incorporates a sales network of agencies and representatives throughout China, which markets Sanchi-based traditional Chinese medicine to hospitals and drug stores as prescription and OTC drugs primarily for the treatment of cardiovascular, cerebrovascular and peptic ulcer disease. The Company also exports medicinal products to Asian countries such as Indonesia, Russia and Kyrgyzstan. For more information, please visit http://www.shenghuo.com.cn .

Safe Harbor Statement

This press release may contain certain "forward-looking statements," as defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate, and the actual results and future events could differ materially from management's current expectations. Such factors include, but are not limited to, risks of litigation and governmental or other regulatory inquiry or proceedings arising out of or related to any of the matters described in recent press releases, including arising out of the restatement of the Company's financial statements; the Company's continuing ability to satisfy any requirements which may be prescribed by the Exchange for continued listing on the Exchange; potential adverse effects to the Company's financial condition, results of operations or prospects as a result of possible changes to or restatements of prior period financial statements; risks arising from potential weaknesses or deficiencies in the Company's internal control over financial reporting; the Company's reliance on one supplier for Sanchi; the possible effect of adverse publicity on the Company's business, including possible contract cancellation; the Company's ability to develop and market new products; the Company's ability to establish and maintain a strong brand; the Company's continued ability to obtain and maintain all certificates, permits and licenses required to open and operate retail specialty counters to offer its cosmetic products and conduct business in China; protection of the Company's intellectual property rights; market acceptance of the Company's products; changes in the laws of the People's Republic of China that affect the Company's operations; cost to the Company of complying with current and future governmental regulations; the impact of any changes in governmental regulations on the Company's operations; general economic conditions; and other factors detailed from time to time in the Company's filings with the United States Securities and Exchange Commission and other regulatory authorities. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

    For more information, please contact:

    China Shenghuo Pharmaceutical Holdings, Inc.
     Mr. Changhua Mu
     Securities Affairs Representative
     Tel:   +86-871-728-2698
     Email: c.mu@chinashenghuo.net

    Grayling Global
     Eddie Cheung
     Investor Relations
     Tel:   +1-646-284-9414
     Email: echeung@hfgcg.com

'/>"/>
SOURCE China Shenghuo Pharmaceutical Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. China Sky One Medical, Inc. Obtains Production Rights for Two New Drugs
2. Greater China suppliers set to end tough 2008 with strong buyer activity at Global Sources Private Sourcing Events
3. Diagnosis and Drug Treatment of Alzheimers Disease in China is Low and Will Remain Low Through 2012
4. China Sky One Medical, Inc. Appoints Yu-bo Hao as CFO
5. Applied Biosystems – Part of Life Technologies – Helps China Respond to Melamine Contamination in Dairy Products : Government and Industry Increase Contaminant Testing to Increase Food Safety
6. CCID Consulting Discusses Chinas Medical Equipment Market
7. China West II Files Suit Against Genesis Pharmaceuticals and Capital Research Group Inc, Announces Conference Call Details
8. China Nepstar Chain Drugstore Reports Third Quarter 2008 Results
9. China Shenghuo Announces Restated Results For Full Year 2007 & First Quarter 2008, Reports Results For Second & Third Quarter 2008
10. ChinaBio(R) Inaugural Partnering Forum Scheduled for June 2009 in Shanghai, China
11. China Documents First Case of Tick-Borne Disease Spread
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... Augustine Insurance Agency, a ... and business owners in the greater Dallas metropolitan area, is announcing a charity ... Foundation. , Established in 2009 by active police professionals in the Dallas region, ...
(Date:12/7/2016)... ... December 07, 2016 , ... Sharon Kleyne, host of the nationally ... Your Health on Voice of America, declared on her radio program in November 2016 ... fact that when these bullies attack leaders in corporate America, they are trying to ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... 20 Marketing Campaign Winner in the Folio: Marketing Awards competition. Live From won ... year’s best in pioneering, inventive, and ultimately successful projects undertaken by the media ...
(Date:12/7/2016)... ... December 07, 2016 , ... Maureen McLaughlin, LA.c., ... Reproductive Medicine Associates of Connecticut (RMACT). McLaughlin brings nearly 20 years of experience ... to help patients realize their family building goals. Acupuncture helps fertility patients ...
(Date:12/7/2016)... ... (PRWEB) December 07, 2016 , ... Angioma Alliance ( ... cavernous angiomas, was awarded a grant from the Julian Grace Foundation to increase ... has more people with cavernous angioma than anywhere in the world. Most share ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... , Dec. 6, 2016  Alopexx Oncology, LLC ... a recombinant antibody fusion protein (immunocytokine) composed of interleukin-2 ... the same target on B cells as Rituxan and ... components but is also involved in tumor targeting, engagement ... vaccine effect. The results of the study (abstract #95954) ...
(Date:12/6/2016)... 2016 Homozygous Familial Hypercholesterolemia (HoFH) ... Global Markets Direct,s latest Pharmaceutical and ... (HoFH) – Pipeline Review, H2 2016, provides ... (HoFH) (Metabolic Disorders) pipeline landscape. Homozygous ... is caused due to mutation from both ...
(Date:12/6/2016)... CENTENNIAL, Colo. , Dec. 6, 2016 /PRNewswire-USNewswire/ ... providers of cartilage, cellular, bone, skin and soft-tissue ... Kimberly Meyer , Business Process Manager, for being ... 2016 Malcolm Baldrige National Quality Award by the ... (NIST), deepening the organization,s commitment to process excellence. ...
Breaking Medicine Technology: